Chlamydia trachomatis infection (“chlamydia”) is the most commonly diagnosed bacterial
sexually transmitted infection (STI) globally with an estimated 130 million new cases each …

Chlamydia trachomatis (CT) screening programs have been established in educational
settings in many countries during the past 2 decades. However, recent evidence suggests …

Background Testing for reinfection at 3 to 6 months following treatment for Chlamydia
Trachomatis or Neisseria gonorrhoea is recommended in best practice sexual health …

Background Patients attending for sexually transmitted infection (STI)/HIV testing may be at
continuing risk of infection and advised to return for retesting at a later date. Objectives To …

Introduction The sexually transmitted infection chlamydia can cause significant
complications, particularly among people with female reproductive organs. Optimal …

Fourteen years on from Hocking and colleagues'1 call for innovative Chlamydia trachomatis
(hereafter referred to as chlamydia) screening programs to reduce the high rates of …

Background Patients at increased risk of sexually transmitted infections (STIs)/HIV
acquisition are advised to reattend for retesting. A previous study showed that 'generic'text …

Background The bacterial load of Chlamydia trachomatis (CT) is assumed to play a role in
transmission and sequelae. We assessed urogenital CT cycle quantification (Cq) values, as …

Background Chlamydia trachomatis (chlamydia) is one of the most common sexually
transmitted infections (STI) globally, and re-infections are common. Current Australian …

Objectives To explore patterns of repeat chlamydia testing among young people in England
and factors associated with testing positive at repeat test. Methods We analysed chlamydia …